children aged five to 11 - International Pharmaceutical Industry

Current Edition

Volume 18 Issue 3

Current Edition

Volume 18 Issue 3

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

News

Positive topline results for Pfizer/BioNTech jab in five to 11-year-olds

Pfizer and BioNTech have announced that their COVID-19 vaccine is safe for use in children aged five to 11 years old. Results from a Phase II/III trial showed a f...

22 September 2021 News BioNTech | children aged five to 11

Continue Reading →